行业洞察美国 FDAT1064
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Revised Draft Guidance for Industry; Availability
🤖 AI 摘要
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry titled "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products." FDA has revised and is reissuing this draft guidance in response to public comments and to changes in drug development by focusing on generating rigorous scientific evidence in the most efficient manner. Advances in our understanding of biological processes and t
分析模型:rule-based-v3 · 07-09 06:59
评分详情
综合分 64/100
信源权威
95
影响范围
70
时效性
50
合规紧急
40
行业关注
35
Federal Register: FDA Notices (官方通知)
操作: